Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M117,290Revenue $M139,367Net Margin (%)3.3Altman Z-Score4.9
Enterprise Value $M128,423EPS $4.0Operating Margin %6.2Piotroski F-Score6
P/E(ttm)25.6Beneish M-Score-2.5Pre-tax Margin (%)5.5Higher ROA y-yN
Price/Book3.210-y EBITDA Growth Rate %12.4Quick Ratio0.7Cash flow > EarningsY
Price/Sales0.85-y EBITDA Growth Rate %11.2Current Ratio1.3Lower Leverage y-yY
Price/Free Cash Flow21.1y-y EBITDA Growth Rate %6.2ROA % (ttm)6.5Higher Current Ratio y-yN
Dividend Yield %1.2PEG2.2ROE % (ttm)12.5Less Shares Outstanding y-yY
Payout Ratio %29.0Shares Outstanding M1,128ROIC % (ttm)11.0Gross Margin Increase y-yN

Gurus Latest Trades with CVS

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
CVSRichard Pzena 2015-03-31 Buy 0.3%$94.16 - $104.56
($101.18)
$ 104.073%New holding527,165
CVSRobert Olstein 2015-03-31 Reduce-0.21%$94.16 - $104.56
($101.18)
$ 104.073%Reduce 24.00%57,000
CVSJoel Greenblatt 2015-03-31 Add0.21%$94.16 - $104.56
($101.18)
$ 104.073%Add 5183.02%272,287
CVSNWQ Managers 2015-03-31 Reduce-0.13%$94.16 - $104.56
($101.18)
$ 104.073%Reduce 8.83%1,173,665
CVSTom Gayner 2015-03-31 Add0.03%$94.16 - $104.56
($101.18)
$ 104.073%Add 5.60%245,000
CVSMario Gabelli 2015-03-31 Reduce-0.03%$94.16 - $104.56
($101.18)
$ 104.073%Reduce 3.43%1,438,163
CVSVanguard Health Care Fund 2015-03-31 Reduce-0.03%$94.16 - $104.56
($101.18)
$ 104.073%Reduce 2.87%3,899,920
CVSJohn Rogers 2015-03-31 Reduce-0.01%$94.16 - $104.56
($101.18)
$ 104.073%Reduce 10.23%84,095
CVSJames Barrow 2015-03-31 Reduce-0.01%$94.16 - $104.56
($101.18)
$ 104.073%Reduce 13.61%304,950
CVSKen Fisher 2015-03-31 Add$94.16 - $104.56
($101.18)
$ 104.073%Add 11.93%158,975
CVSNWQ Managers 2014-12-31 Reduce-0.57%$78.81 - $98.25
($88.16)
$ 104.0718%Reduce 33.62%1,287,296
CVSChris Davis 2014-12-31 Sold Out -0.53%$78.81 - $98.25
($88.16)
$ 104.0718%Sold Out0
CVSRobert Olstein 2014-12-31 Reduce-0.18%$78.81 - $98.25
($88.16)
$ 104.0718%Reduce 18.48%75,000
CVSVanguard Health Care Fund 2014-12-31 Reduce-0.08%$78.81 - $98.25
($88.25)
$ 104.0718%Reduce 8.50%4,015,136
CVSTom Gayner 2014-12-31 Add0.04%$78.81 - $98.25
($88.25)
$ 104.0718%Add 6.42%232,000
CVSMario Gabelli 2014-12-31 Reduce-0.02%$78.81 - $98.25
($88.25)
$ 104.0718%Reduce 2.54%1,489,263
CVSKen Fisher 2014-12-31 Add$78.81 - $98.25
($88.25)
$ 104.0718%Add 0.91%142,036
CVSRuane Cunniff 2014-12-31 Reduce$78.81 - $98.25
($88.25)
$ 104.0718%Reduce 6.03%24,953
CVSJoel Greenblatt 2014-12-31 Reduce$78.81 - $98.25
($88.32)
$ 104.0718%Reduce 44.87%5,154
CVSJohn Rogers 2014-12-31 Reduce$78.81 - $98.25
($88.25)
$ 104.0718%Reduce 1.68%93,675
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

CVS is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


CVS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BROWN C DAVID IIDirector 2015-05-01Sell15,000$100.273.57view
Sussman AndrewEVP & Pres, CVS/minuteclinic 2015-04-10Sell17,638$102.381.44view
Brennan Troyen AEVP, Chief Medical Officer 2015-04-02Sell33,384$102.481.34view
Brennan Troyen AEVP, Chief Medical Officer 2015-03-23Sell33,274$104.94-1.04view
BROWN C DAVID IIDirector 2015-03-20Sell25,000$104.3-0.43view
Roberts Jonathan CEVP & President, CVS/caremark 2015-01-07Sell86,487$95.318.96view
MERLO LARRY JPresident and CEO 2015-01-05Sell144,144$94.310.13view
Sussman AndrewSVP & Pres, CVS/minuteclinic 2015-01-02Sell4,220$95.678.55view
Brennan Troyen AEVP, Chief Medical Officer 2015-01-02Sell50,240$95.718.5view
Lofberg Per GHEVP 2015-01-02Sell347,343$95.288.99view

Press Releases about CVS :

    Quarterly/Annual Reports about CVS:

    News about CVS:

    Articles On GuruFocus.com
    Glenview Capital Raises Stake In Monsanto May 21 2015 
    Compass Capital Management's Top 3 Picks During Q1 May 11 2015 
    Richard Pzena Makes 12 New Buys in First Quarter May 11 2015 
    Steven Romick's FPA Crescent Fund First Quarter 2015 Commentary May 06 2015 
    6 Dividend Stocks Trading at a Double-Digit Discount Apr 22 2015 
    Rite Aid Posts Impressive Q4 Results But Disappointing 2016 Guidance Apr 10 2015 
    CVS Health Corporation (CVS) Dividend Stock Analysis Apr 07 2015 
    Rite Aid – What To Expect From Q4 And Full Fiscal Earnings Report Tomorrow Apr 07 2015 
    UnitedHealth Group Is Ready For A Huge Pharmacy Deal Apr 06 2015 
    UnitedHealth Planning Catamaran Corp’s Acquisition For $12.78 Billion Apr 02 2015 

    More From Other Websites
    12 Worst Buys in Funds May 22 2015
    The word is this company could be the target of the next big healthcare deal — and now the stock... May 22 2015
    SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Omnicare Inc. of Commencement of... May 22 2015
    CVS Health (CVS) Stock Price Target Increased by Analysts May 22 2015
    3 Consumer ETFs to Gain on CVS Health Buyout - ETF News And Commentary May 22 2015
    The Zacks Analyst Blog Highlights: Wal-Mart Stores, Amazon.com, Jack in the Box, American Eagle... May 22 2015
    May 22 Premarket Briefing: 10 Things You Should Know May 22 2015
    How Pricey Specialty Drugs Spurred CVS Health's Omnicare Deal May 22 2015
    Five things you need to know today, and Cincinnati loses a Fortune 500 company May 22 2015
    CVS Health Surges on Heavy Trade, Heading for New Highs May 22 2015
    In a quiet stock market, whispers of an M&A wave May 22 2015
    Lean times for the diet industry May 22 2015
    Jim Cramer: Here’s One of the Stupidest Things Investors Do May 22 2015
    [$$] CVS Ages Gracefully With Omnicare Deal May 21 2015
    As Express Scripts Attacks Costs, Investors Will Profit May 21 2015
    Cramer Remix: Why you need to avoid Chinese stocks May 21 2015
    5 plays on big-name retail stocks May 21 2015
    Cramer: Mergers that could unlock riches for you May 21 2015
    As CVS Swoops Up Old Suitor, PharMerica’s Single and Loving It May 21 2015
    Cramer: Stupid decisions ruining your portfolio May 21 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK